Greenvention Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.79 M
- Revenue Growth -10.29%
- Profit Growth -8015.04%
- Ebitda -1623.66%
- Net Worth -549.65%
- Total Assets 79.77%
About Greenvention Biotech
Greenvention Biotech Private Limited (GBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 June 2016 (Eight years and seven months 11 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.79 M.
Santosh Tupe and Mukund Deshpande serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200PN2016PTC165126
-
Company No.
165126
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 2016
-
Date of AGM
31 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Greenvention Biotech Private Limited offer?
Greenvention Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Plant Growth Promoters.
Who are the key members and board of directors at Greenvention Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Tupe
|
Director | 22-Jun-2016 | Current |
|
Mukund Deshpande
|
Director | 22-Jun-2016 | Current |
Financial Performance of Greenvention Biotech.
Greenvention Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.29% decrease. The company also saw a substantial fall in profitability, with a 8015.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 549.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenvention Biotech?
In 2018, Greenvention Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.79 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2020 | Others | ₹0.69 M | Open |
| 20 Apr 2019 | Others | ₹7.10 M | Open |
How Many Employees Work at Greenvention Biotech?
Unlock and access historical data on people associated with Greenvention Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenvention Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenvention Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
